Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 79

    1.

    Psychological and immunological reactions of family members to patients undergoing bone marrow transplantation.

    Futterman AD, Wellisch DK, Zighelboim J, Luna-Raines M, Weiner H.

    Psychosom Med. 1996 Sep-Oct;58(5):472-80.PMID: 8902898 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Methods for studying intestinal sensitivity and compliance: in vitro studies of balloons and a barostat.

    Toma TP, Zighelboim J, Phillips SF, Talley NJ.

    Neurogastroenterol Motil. 1996 Mar;8(1):19-28.PMID: 8697181 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lupus anticoagulant masquerading as an acute abdomen with multiorgan involvement.

    Gaspari JC, Sande JR, Thomas CF Jr, Zighelboim J, Camilleri M.

    Am J Gastroenterol. 1995 May;90(5):825-6.PMID: 7733097 [PubMed - indexed for MEDLINE]Related articles

    4.

    Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism.

    Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR.

    Dig Dis Sci. 1995 Apr;40(4):819-27.PMID: 7720476 [PubMed - indexed for MEDLINE]Related articles

    5.

    Abnormalities in the shape of the duodenal loop on X-ray. Associated with idiopathic antral hypomotility?

    Zighelboim J, MacCarty RL, Talley NJ.

    Dig Dis Sci. 1995 Jan;40(1):128-33.PMID: 7821099 [PubMed - indexed for MEDLINE]Related articles

    6.

    Response of gastric fundus to rectal distension in healthy persons.

    Zighelboim J, Talley NJ, Phillips SF.

    Dig Dis Sci. 1994 Jul;39(7):1441-5.PMID: 8026254 [PubMed - indexed for MEDLINE]Related articles

    7.

    Primary colonic lymphoma. Clinical presentation, histopathologic features, and outcome with combination chemotherapy.

    Zighelboim J, Larson MV.

    J Clin Gastroenterol. 1994 Jun;18(4):291-7.PMID: 8071513 [PubMed - indexed for MEDLINE]Related articles

    8.

    A patient with diarrhea, arthralgias, and fever.

    Zighelboim J, Carpenter HA, Talley NJ.

    Gastroenterology. 1993 Sep;105(3):923-30. No abstract available. PMID: 7689523 [PubMed - indexed for MEDLINE]Related articles

    9.

    Endoscopic laser coagulation of radiation-induced mucosal vascular lesions in the upper gastrointestinal tract and proximal colon.

    Zighelboim J, Viggiano TR, Ahlquist DA, Gostout CJ, Wang KK, Larson MV.

    Am J Gastroenterol. 1993 Aug;88(8):1224-7.PMID: 8338089 [PubMed - indexed for MEDLINE]Related articles

    10.

    Endoscopic Nd:YAG laser coagulation of bleeding from radiation proctopathy.

    Viggiano TR, Zighelboim J, Ahlquist DA, Gostout CJ, Wang KK, Larson MV.

    Gastrointest Endosc. 1993 Jul-Aug;39(4):513-7.PMID: 8365598 [PubMed - indexed for MEDLINE]Related articles

    11.

    What are functional bowel disorders?

    Zighelboim J, Talley NJ.

    Gastroenterology. 1993 Apr;104(4):1196-201. Review. No abstract available. Erratum in: Gastroenterology 1993 Aug;105(2):649. PMID: 8462809 [PubMed - indexed for MEDLINE]Related articles

    12.

    Will a NaH14CO3-capsule method accurately measure gastric emptying?

    Zighelboim J, Talley NJ, Mullan BP, Camilleri M, Thomforde G.

    Am J Gastroenterol. 1993 Mar;88(3):462-4. No abstract available. PMID: 8382452 [PubMed - indexed for MEDLINE]Related articles

    13.

    Successful medical management of a patient with multiple hepatic abscesses due to Edwardsiella tarda.

    Zighelboim J, Williams TW Jr, Bradshaw MW, Harris RL.

    Clin Infect Dis. 1992 Jan;14(1):117-20.PMID: 1571414 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prostatic abscess due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome.

    Zighelboim J, Goldfarb RA, Mody D, Williams TW, Bradshaw MW, Harris RL.

    J Urol. 1992 Jan;147(1):166-8.PMID: 1729520 [PubMed - indexed for MEDLINE]Related articles

    15.

    Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.

    Bonavida B, Tsuchitani T, Zighelboim J, Berek JS.

    Gynecol Oncol. 1990 Sep;38(3):333-9.PMID: 2227544 [PubMed - indexed for MEDLINE]Related articles

    16.

    Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers.

    Nio Y, Zighelboim J, Berek JS, Bonavida B.

    Anticancer Res. 1990 Mar-Apr;10(2A):441-6.PMID: 2346317 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells.

    Nio Y, Zighelboim J, Berek J, Bonavida B.

    Cancer Chemother Pharmacol. 1990;26(1):1-8.PMID: 2322985 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.

    Nio Y, Zighelboim J, Berek JS, Bonavida B.

    Nat Immun Cell Growth Regul. 1990;9(4):283-96.PMID: 2215516 [PubMed - indexed for MEDLINE]Related articles

    19.

    Human neutrophil-mediated lysis of ovarian cancer cells.

    Lichtenstein A, Seelig M, Berek J, Zighelboim J.

    Blood. 1989 Aug 1;74(2):805-9.PMID: 2546632 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells.

    Nio Y, Zighelboim J, Berek J, Bonavida B.

    Cancer. 1989 Jul 15;64(2):434-41.PMID: 2736490 [PubMed - indexed for MEDLINE]Related articles

    21.

    Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients.

    Boyer PJ, Berek JS, Zighelboim J.

    Obstet Gynecol. 1989 May;73(5 Pt 1):793-7.PMID: 2784847 [PubMed - indexed for MEDLINE]Related articles

    22.

    Intraperitoneal administration of human recombinant interferon-alpha in patients with ovarian cancer: effects on lymphocyte phenotype and cytotoxicity.

    Lichtenstein A, Spina C, Berek JS, Jung T, Zighelboim J.

    Cancer Res. 1988 Oct 15;48(20):5853-9.PMID: 3167841 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.

    Nio Y, Zighelboim J, Berek JS, Bonavida B.

    Cancer Immunol Immunother. 1988;27(3):246-54.PMID: 3180149 [PubMed - indexed for MEDLINE]Related articles

    24.

    Immunologic control of ovarian cancer.

    Zighelboim J, Nio Y, Berek JS, Bonavida B.

    Nat Immun Cell Growth Regul. 1988;7(4):216-25. No abstract available. PMID: 3070371 [PubMed - indexed for MEDLINE]Related articles

    25.

    Antigen-specific suppression of the in vitro cytotoxic response by a soluble factor produced by Corynebacterium parvum-induced allospecific suppressor cells.

    Terpenning M, Lichtenstein AK, Zighelboim J.

    Cell Immunol. 1987 Feb;104(2):271-80.PMID: 2949854 [PubMed - indexed for MEDLINE]Related articles

    26.

    Monoclonal antibodies against squamous cell carcinoma.

    Eskinazi DP, Molinaro GA, Abemayor E, Martin SE, Zighelboim J.

    Oral Surg Oral Med Oral Pathol. 1985 Oct;60(4):377-81.PMID: 3903597 [PubMed - indexed for MEDLINE]Related articles

    27.

    Synergistic effects of combination sequential immunotherapies in a murine ovarian cancer model.

    Berek JS, Lichtenstein AK, Knox RM, Jung TS, Rose TP, Cantrell JL, Zighelboim J.

    Cancer Res. 1985 Sep;45(9):4215-8.PMID: 4028011 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy.

    Champlin RE, Ho WG, Gale RP, Winston D, Selch M, Mitsuyasu R, Lenarsky C, Elashoff R, Zighelboim J, Feig SA.

    Ann Intern Med. 1985 Mar;102(3):285-91.PMID: 3882039 [PubMed - indexed for MEDLINE]Related articles

    29.

    Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer.

    Lichtenstein AK, Berek J, Zighelboim J.

    J Natl Cancer Inst. 1985 Feb;74(2):349-55.PMID: 3856049 [PubMed - indexed for MEDLINE]Related articles

    30.

    Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer.

    Berek JS, Bast RC Jr, Lichtenstein A, Hacker NF, Spina CA, Lagasse LD, Knapp RC, Zighelboim J.

    Obstet Gynecol. 1984 Nov;64(5):708-14.PMID: 6493663 [PubMed - indexed for MEDLINE]Related articles

    31.

    Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.

    Lichtenstein AK, Berek J, Kahle J, Zighelboim J.

    Cancer Res. 1984 Nov;44(11):5118-23.PMID: 6488171 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.

    Lichtenstein A, Berek J, Bast R, Spina C, Hacker N, Knapp RC, Zighelboim J.

    J Biol Response Mod. 1984 Aug;3(4):371-8.PMID: 6541243 [PubMed - indexed for MEDLINE]Related articles

    34.

    Immunotherapy with biochemically dissociated fractions of Propionibacterium acnes in a murine ovarian cancer model.

    Berek JS, Cantrell JL, Lichtenstein AK, Hacker NF, Knox RM, Nieberg RK, Poth T, Elashoff RM, Lagasse LD, Zighelboim J.

    Cancer Res. 1984 May;44(5):1871-5.PMID: 6713388 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Peripheral blood lymphocytes with receptors for a determinant common to B-lymphoblastoid cell lines and acute myelogenous leukemia blasts.

    Lichtenstein A, Naiem F, Zighelboim J.

    Am J Hematol. 1984 May;16(4):383-91.PMID: 6202138 [PubMed - indexed for MEDLINE]Related articles

    36.

    Prolonged survival in acute myelogenous leukaemia without maintenance chemotherapy.

    Champlin R, Jacobs A, Gale RP, Boccia R, Elashoff R, Foon K, Zighelboim J.

    Lancet. 1984 Apr 21;1(8382):894-6.PMID: 6200742 [PubMed - indexed for MEDLINE]Related articles

    37.

    AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemia.

    Boccia R, Zighelboim J, Champlin RE, Kim CC, Gale RP.

    Med Pediatr Oncol. 1984;12(3):178-9.PMID: 6587178 [PubMed - indexed for MEDLINE]Related articles

    38.

    Inhibition of natural killer cell lysis by natural killer-inhibitory substance: mechanism of suppression.

    Lichtenstein A, Mickel R, Zighelboim J.

    Cell Immunol. 1983 Aug;80(1):66-77.PMID: 6191875 [PubMed - indexed for MEDLINE]Related articles

    39.

    Regulation of cytotoxic reactivity to minor histocompatibility antigens by administration of Corynebacterium parvum.

    Lichtenstein A, Ali M, Mack P, Zighelboim J.

    Transplantation. 1983 Jun;35(6):582-8.PMID: 6191416 [PubMed - indexed for MEDLINE]Related articles

    40.

    Inhibition of natural killer cell activity by a soluble substance released by rat peritoneal cells.

    Zighelboim J, Lichtenstein A, Bick A, Mickel R.

    Cancer Res. 1983 May;43(5):1984-9.PMID: 6339046 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Augmentation of NK activity by Corynebacterium parvum fractions in vivo and in vitro.

    Lichtenstein A, Bick A, Cantrell J, Zighelboim J.

    Int J Immunopharmacol. 1983;5(2):137-44.PMID: 6874167 [PubMed - indexed for MEDLINE]Related articles

    42.

    Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice.

    Lichtenstein A, Tuttle R, Cantrell J, Zighelboim J.

    J Natl Cancer Inst. 1982 Aug;69(2):495-501.PMID: 6213807 [PubMed - indexed for MEDLINE]Related articles

    43.

    Treatment of acute myelogenous leukemia in older patients.

    Foon KA, Zighelboim J, Gale RP.

    N Engl J Med. 1981 Dec 10;305(24):1470. No abstract available. PMID: 6946284 [PubMed - indexed for MEDLINE]Related articles

    44.

    Activation and mechanism of action of suppressor macrophages.

    Lichtenstein A, Murahata R, Terpenning M, Cantrell J, Zighelboim J.

    Cell Immunol. 1981 Oct;64(1):150-61. No abstract available. PMID: 6457695 [PubMed - indexed for MEDLINE]Related articles

    45.

    Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia.

    Foon KA, Zighelboim J, Yale C, Gale RP.

    Blood. 1981 Sep;58(3):467-70.PMID: 6942845 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Response of normal subjects to mitogens. I. Influence of adherent cells.

    Zighelboim J, Lichtenstein A, Benjamin D.

    Clin Immunol Immunopathol. 1981 Jun;19(3):406-15. No abstract available. PMID: 7249418 [PubMed - indexed for MEDLINE]Related articles

    47.

    Intensive chemotherapy for acute myelogenous leukemia.

    Gale RP, Foon KA, Cline MJ, Zighelboim J.

    Ann Intern Med. 1981 Jun;94(6):753-7.PMID: 6940466 [PubMed - indexed for MEDLINE]Related articles

    48.

    Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.

    Lichtenstein A, Murahata R, Sugasawara R, Zighelboim J.

    Cell Immunol. 1981 Mar 1;58(2):257-68. No abstract available. PMID: 6452218 [PubMed - indexed for MEDLINE]Related articles

    49.

    cis-Diamminedichloroplatinum(II) alone and in combination in the treatment of testicular and other malignancies.

    Sarna G, Skinner DG, Smith RB, Zighelboim J, Goodnight JE, Feig S.

    Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1077-82.PMID: 7193086 [PubMed - indexed for MEDLINE]Related articles

    50.

    Peripheral blood lymphocyte receptors for B-lymphoblastoid cell lines (B-LCL).

    Zighelboim J, Lichtenstein A.

    Blood. 1980 Oct;56(4):690-5.PMID: 6968233 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...